Discover 1,776 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Durham NC, Pinehurst NC, Lynchburg VA, Gaffney SC,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
New
Effect of Late Ripcord Removal From Glaucoma Drainage Device
for
GLAUCOMA 1, OPEN ANGLE, D (Disorder), Glaucoma
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT07803536
Recruiting
Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment
for
Smoking
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 21+
Code: NCT07089901
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Durham NC, Gaffney SC, Florence SC, Union SC,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
for
Non-muscle Invasive Bladder Cancer
Location: Durham NC, Myrtle Beach SC, Atlanta GA, Nashville TN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07206225
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Overnight TI in TLE
for
Temporal Lobe Epilepsy (TLE), Drug Resistant Epilepsy, Sleep
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18 - 70
Code: NCT07434986
Recruiting
Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence
for
Nicotine Dependence
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18 - 65
Code: NCT02635919
Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation